Human Phenotype Ontology 
Grandparent Node:
expand
Adrenal insufficiency (HP:0000846)help
Parent Node:
expand
Primary adrenal insufficiency (HP:0008207)help
..Starting node
..expand
Decreased circulating aldosterone level (HP:0004319)help
Term ID: 4319
Name: Decreased circulating aldosterone level
Synonym: Decreased aldosterone; Decreased aldosterone production; Decreased serum aldosterone; Hypoaldosteronism; Low blood aldosterone level; Mineralocorticoid insufficiency
Definition: Abnormally reduced levels of aldosterone.
Comments:
Reference: HP:0004319
Genes and Diseases:
 
       Child Nodes:

 Sister Nodes: 
..expandDecreased circulating cortisol level (HP:0008163) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0004319HP:0004319Decreased circulating aldosterone level0AAAS CL E G H808613666OMIM:231550Achalasia-Addisonianism-Alacrima syndrome.57
HP:0004319HP:0004319Decreased circulating aldosterone level0AIRE CL E G H326360OMIM:240300AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I, WITH OR WITHOUT REVERSIBLE METAPHYSEAL DYSPLASIA; APS192
HP:0004319HP:0004319Decreased circulating aldosterone level0AIRE CL E G H326360ORPHA:3453Autoimmune polyendocrinopathy type 1HP:0040281 - Very frequent92
HP:0004319HP:0004319Decreased circulating aldosterone level0CYP11A1 CL E G H15832590ORPHA:16855846,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiencyHP:0040281 - Very frequent31
HP:0004319HP:0004319Decreased circulating aldosterone level0CYP11A1 CL E G H15832590ORPHA:289548Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiencyHP:0040281 - Very frequent31
HP:0004319HP:0004319Decreased circulating aldosterone level0CYP11B1 CL E G H15842591OMIM:202010Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency112
HP:0004319HP:0004319Decreased circulating aldosterone level0CYP11B2 CL E G H15852592OMIM:203400Corticosterone methyloxidase type I deficiency.73
HP:0004319HP:0004319Decreased circulating aldosterone level0CYP11B2 CL E G H15852592ORPHA:556030Early-onset familial hypoaldosteronismHP:0040282 - Frequent73
HP:0004319HP:0004319Decreased circulating aldosterone level0CYP11B2 CL E G H15852592OMIM:610600Hypoaldosteronism, congenital, due to CMO II deficiency73
HP:0004319HP:0004319Decreased circulating aldosterone level0CYP17A1 CL E G H15862593ORPHA:90793Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiencyHP:0040282 - Frequent53
HP:0004319HP:0004319Decreased circulating aldosterone level0HSD11B2 CL E G H32915209ORPHA:320Apparent mineralocorticoid excessHP:0040282 - Frequent14
HP:0004319HP:0004319Decreased circulating aldosterone level0HSD11B2 CL E G H32915209OMIM:218030Apparent mineralocorticoid excess.14
HP:0004319HP:0004319Decreased circulating aldosterone level0HSD3B2 CL E G H32845218ORPHA:90791Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiencyHP:0040282 - Frequent34
HP:0004319HP:0004319Decreased circulating aldosterone level0MC2R CL E G H41586930ORPHA:361Familial glucocorticoid deficiencyHP:0040283 - Occasional94
HP:0004319HP:0004319Decreased circulating aldosterone level0MRAP CL E G H562461304ORPHA:361Familial glucocorticoid deficiencyHP:0040283 - Occasional26
HP:0004319HP:0004319Decreased circulating aldosterone level0NNT CL E G H235307863ORPHA:361Familial glucocorticoid deficiencyHP:0040283 - Occasional13
HP:0004319HP:0004319Decreased circulating aldosterone level0NR0B1 CL E G H1907960OMIM:300200Adrenal hypoplasia, congenital.48
HP:0004319HP:0004319Decreased circulating aldosterone level0NR3C1 CL E G H29087978ORPHA:786Generalized glucocorticoid resistance syndromeHP:0040281 - Very frequent79
HP:0004319HP:0004319Decreased circulating aldosterone level0NR3C2 CL E G H43067979OMIM:605115Hypertension, early-onset, autosomal dominant, with severe exacerbationin pregnancy.109
HP:0004319HP:0004319Decreased circulating aldosterone level0SCNN1B CL E G H633810600OMIM:177200Liddle syndrome 1.61
HP:0004319HP:0004319Decreased circulating aldosterone level0SCNN1G CL E G H634010602OMIM:618114Liddle syndrome 257
HP:0004319HP:0004319Decreased circulating aldosterone level0STAR CL E G H677011359ORPHA:361Familial glucocorticoid deficiencyHP:0040283 - Occasional45
HP:0004319HP:0004319Decreased circulating aldosterone level0TXNRD2 CL E G H1058718155ORPHA:361Familial glucocorticoid deficiencyHP:0040283 - Occasional85


Genes (18) :AAAS AIRE CYP11A1 CYP11B1 CYP11B2 CYP17A1 HSD11B2 HSD3B2 MC2R MRAP NNT NR0B1 NR3C1 NR3C2 SCNN1B SCNN1G STAR TXNRD2

Diseases (19) :OMIM:231550 OMIM:240300 ORPHA:3453 ORPHA:168558 ORPHA:289548 OMIM:202010 OMIM:203400 ORPHA:556030 OMIM:610600 ORPHA:90793 ORPHA:320 OMIM:218030 ORPHA:90791 ORPHA:361 OMIM:300200 ORPHA:786 OMIM:605115 OMIM:177200 OMIM:618114
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.